The Rabies Antiserum Market size is expected to grow at an annual average CAGR of 6% during 2022-2028. The purpose of this guidance is to assist sponsors in developing a rabies virus monoclonal antibody (mAb) cocktail as an alternative to rabies virus immunoglobulin (RIG). Prevention of rabies when administered immediately after contact with rabies or potentially […]
